nodes	percent_of_prediction	percent_of_DWPC	metapath
Iron—Paraesthesia—Fludarabine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Iron—Hypoaesthesia—Carmustine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Iron—Sweating—Mitoxantrone—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Iron—Dyspnoea—Fludarabine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Iron—Haematuria—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Iron—Oedema peripheral—Carmustine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Iron—Dyspepsia—Fludarabine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Iron—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Iron—Decreased appetite—Fludarabine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Iron—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Iron—Fatigue—Fludarabine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Iron—Inflammation—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Iron—Hypoaesthesia—Vincristine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Iron—Pain—Fludarabine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Iron—Constipation—Fludarabine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Iron—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Iron—Eye disorder—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Iron—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Iron—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Iron—Hypersensitivity—Teniposide—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iron—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iron—Flushing—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iron—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Iron—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Iron—Anaemia—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Iron—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Iron—Asthenia—Teniposide—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Iron—Melaena—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Iron—Malaise—Bleomycin—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Iron—Pruritus—Teniposide—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Iron—Arrhythmia—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Iron—Body temperature increased—Fludarabine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Iron—Erythema—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Iron—Malnutrition—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Iron—Cough—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Iron—Angiopathy—Vincristine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Iron—Diarrhoea—Teniposide—lymphatic system cancer	0.002	0.002	CcSEcCtD
Iron—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Iron—Chest pain—Bleomycin—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Iron—Myalgia—Bleomycin—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Iron—Back pain—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Iron—Discomfort—Bleomycin—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Iron—Chills—Mitoxantrone—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Iron—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Iron—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iron—Confusional state—Bleomycin—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iron—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Iron—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Iron—Oedema—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Iron—Erythema—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Iron—Infection—Bleomycin—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Iron—Anaemia—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Iron—Back pain—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Iron—Vomiting—Teniposide—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Iron—Sepsis—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Iron—Agitation—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Iron—Asthenia—Fludarabine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iron—Rash—Teniposide—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iron—Dermatitis—Teniposide—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iron—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iron—Headache—Teniposide—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iron—Pruritus—Fludarabine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Iron—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iron—Back pain—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iron—Anorexia—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Iron—Anaemia—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Iron—Agitation—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Iron—Hypotension—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iron—Diarrhoea—Fludarabine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iron—Convulsion—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iron—Hypertension—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iron—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iron—Nausea—Teniposide—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iron—Anaemia—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iron—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Iron—Myalgia—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Iron—Chest pain—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Iron—Paraesthesia—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Iron—Malaise—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Iron—Dyspnoea—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iron—Convulsion—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Iron—Hypertension—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Iron—Confusional state—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Iron—Oedema—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Iron—Decreased appetite—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Iron—Myalgia—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Iron—Cough—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Iron—Infection—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Iron—Vomiting—Fludarabine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Iron—Convulsion—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iron—Rash—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iron—Dermatitis—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iron—Hypertension—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iron—Pain—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Iron—Headache—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Iron—Tachycardia—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Iron—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Iron—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Iron—Myalgia—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Iron—Chest pain—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Iron—Discomfort—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Iron—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Iron—Oedema—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Iron—Anorexia—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Iron—Infection—Vincristine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Iron—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Iron—Confusional state—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Iron—Nervous system disorder—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Iron—Hypotension—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Iron—Oedema—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Iron—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Iron—Nausea—Fludarabine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Iron—Infection—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Iron—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Iron—Shock—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Iron—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Iron—Urticaria—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Iron—Anorexia—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Iron—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Iron—Body temperature increased—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Iron—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Iron—Paraesthesia—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Iron—Hypotension—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Iron—Dyspnoea—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Iron—Somnolence—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Iron—Anorexia—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Iron—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iron—Decreased appetite—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iron—Hypotension—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iron—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Iron—Paraesthesia—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Iron—Constipation—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iron—Pain—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iron—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Iron—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Iron—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Iron—Decreased appetite—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Iron—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Iron—Somnolence—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Iron—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iron—Feeling abnormal—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iron—Fatigue—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iron—Asthenia—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iron—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iron—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iron—Pain—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iron—Constipation—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iron—Pruritus—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Iron—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Iron—Fatigue—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Iron—Pain—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iron—Constipation—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iron—Body temperature increased—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iron—Abdominal pain—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iron—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Iron—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Iron—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Iron—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Iron—Body temperature increased—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Iron—Abdominal pain—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Iron—Urticaria—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iron—Hypersensitivity—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iron—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iron—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iron—Pneumonia—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Iron—Vomiting—Bleomycin—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Iron—Infestation—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Iron—Infestation NOS—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Iron—Rash—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Iron—Dermatitis—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Iron—Asthenia—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Iron—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Iron—Hypersensitivity—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Iron—Sweating—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Iron—Haematuria—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Iron—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Iron—Asthenia—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Iron—Diarrhoea—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iron—Nausea—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iron—Asthenia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Iron—Dizziness—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Iron—Haemoglobin—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Iron—Diarrhoea—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iron—Haemorrhage—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iron—Pharyngitis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Iron—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Iron—Vomiting—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Iron—Dizziness—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Iron—Rash—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Iron—Dermatitis—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Iron—Headache—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Iron—Eye disorder—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Iron—Vomiting—Vincristine—lymphatic system cancer	0.000997	0.000997	CcSEcCtD
Iron—Rash—Vincristine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Iron—Dermatitis—Vincristine—lymphatic system cancer	0.000988	0.000988	CcSEcCtD
Iron—Headache—Vincristine—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Iron—Nausea—Carmustine—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Iron—Angiopathy—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Iron—Vomiting—Mitoxantrone—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Iron—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Iron—Rash—Mitoxantrone—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Iron—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000962	0.000962	CcSEcCtD
Iron—Chills—Methotrexate—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Iron—Headache—Mitoxantrone—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Iron—Erythema—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Iron—Malnutrition—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Iron—Nausea—Vincristine—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Iron—Dysgeusia—Methotrexate—lymphatic system cancer	0.000913	0.000913	CcSEcCtD
Iron—Nausea—Mitoxantrone—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Iron—Back pain—Methotrexate—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Iron—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000865	0.000865	CcSEcCtD
Iron—Anaemia—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Iron—Malaise—Methotrexate—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Iron—Cough—Methotrexate—lymphatic system cancer	0.000814	0.000814	CcSEcCtD
Iron—Convulsion—Methotrexate—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Iron—Myalgia—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Iron—Arthralgia—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Iron—Chest pain—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Iron—Discomfort—Methotrexate—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Iron—Confusional state—Methotrexate—lymphatic system cancer	0.000767	0.000767	CcSEcCtD
Iron—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Iron—Infection—Methotrexate—lymphatic system cancer	0.000756	0.000756	CcSEcCtD
Iron—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000746	0.000746	CcSEcCtD
Iron—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000736	0.000736	CcSEcCtD
Iron—Anorexia—Methotrexate—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Iron—Hypotension—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Iron—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Iron—Paraesthesia—Methotrexate—lymphatic system cancer	0.000683	0.000683	CcSEcCtD
Iron—Dyspnoea—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Iron—Somnolence—Methotrexate—lymphatic system cancer	0.000677	0.000677	CcSEcCtD
Iron—Dyspepsia—Methotrexate—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Iron—Decreased appetite—Methotrexate—lymphatic system cancer	0.000662	0.000662	CcSEcCtD
Iron—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000657	0.000657	CcSEcCtD
Iron—Fatigue—Methotrexate—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Iron—Pain—Methotrexate—lymphatic system cancer	0.000651	0.000651	CcSEcCtD
Iron—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Iron—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Iron—Urticaria—Methotrexate—lymphatic system cancer	0.000605	0.000605	CcSEcCtD
Iron—Abdominal pain—Methotrexate—lymphatic system cancer	0.000602	0.000602	CcSEcCtD
Iron—Body temperature increased—Methotrexate—lymphatic system cancer	0.000602	0.000602	CcSEcCtD
Iron—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Iron—Asthenia—Methotrexate—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Iron—Pruritus—Methotrexate—lymphatic system cancer	0.000538	0.000538	CcSEcCtD
Iron—Diarrhoea—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Iron—Dizziness—Methotrexate—lymphatic system cancer	0.000503	0.000503	CcSEcCtD
Iron—Vomiting—Methotrexate—lymphatic system cancer	0.000484	0.000484	CcSEcCtD
Iron—Rash—Methotrexate—lymphatic system cancer	0.00048	0.00048	CcSEcCtD
Iron—Dermatitis—Methotrexate—lymphatic system cancer	0.000479	0.000479	CcSEcCtD
Iron—Headache—Methotrexate—lymphatic system cancer	0.000477	0.000477	CcSEcCtD
Iron—Nausea—Methotrexate—lymphatic system cancer	0.000452	0.000452	CcSEcCtD
